REQUEST A DEMO
Total
USD $0.00
Search more companies

Instytut Hematologii I Transfuzjologii (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Ambulatory Health Care Services | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals
Full name: Instytut Hematologii I Transfuzjologii Profile Updated: February 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Instytut Hematologii I Transfuzjologii is a company in Poland, with a head office in Warsaw. The enterprise currently operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. It was established on June 19, 2002. It currently has a total number of 501 - 1,000 (2024) employees. From the latest financial highlights, Instytut Hematologii I Transfuzjologii reported a net sales revenue increase of 18.42% in 2024. Its’ total assets recorded a negative growth of 2.89%. The net profit margin of Instytut Hematologii I Transfuzjologii increased by 0.79% in 2024.

Headquarters
Ul. Gandhi Indiry 14
Warsaw; Mazowieckie; Postal Code: 02-776

Contact Details: Purchase the Instytut Hematologii I Transfuzjologii report to view the information.

Website: http://www.ihit.waw.pl

Basic Information
Total Employees:
Purchase the Instytut Hematologii I Transfuzjologii report to view the information.
Financial Auditors:
Purchase the Instytut Hematologii I Transfuzjologii report to view the information.
Incorporation Date:
June 19, 2002
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Instytut Hematologii I Transfuzjologii report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
18.42%
Total operating revenue
18.41%
Operating profit (EBIT)
90.51%
EBITDA
31.01%
Net Profit (Loss) for the Period
85.64%
Total assets
-2.89%
Total equity
19.49%
Operating Profit Margin (ROS)
0.59%
Net Profit Margin
0.79%
Return on Equity (ROE)
5.81%
Quick Ratio
0.05%
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?